Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Gastrointestinal 21Other 20Genitourinary 19Breast 14Head & Neck 7Gynecologic 6Thoracic 2Other hematologic neoplasm 2Lymphoid 2Endocrine 2Dermatologic 2Other neoplasm 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 3102Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Leukemia 2013Leukemia, Lymphocytic, Chronic, B-Cell 1771Myelodysplastic Syndromes 1298Hematologic Neoplasms 1067Lymphoma 1029Lymphoma, Non-Hodgkin 981Leukemia, Myelogenous, Chronic, BCR-ABL Positive 713Lymphoma, Follicular 704Lymphoma, Mantle-Cell 678Lymphoma, Large B-Cell, Diffuse 657Burkitt Lymphoma 642Multiple Myeloma 639Lymphoma, B-Cell, Marginal Zone 599Recurrence 587Hodgkin Disease 575Leukemia, Myelomonocytic, Chronic 495Lymphoma, Large-Cell, Immunoblastic 419Neoplasms 402Myeloproliferative Disorders 402Leukemia, Myeloid, Chronic-Phase 391Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 382Congenital Abnormalities 357Waldenstrom Macroglobulinemia 330Blast Crisis 324Leukemia, Myeloid, Accelerated Phase 290Lymphoma, T-Cell, Cutaneous 280Primary Myelofibrosis 270Anemia, Refractory, with Excess of Blasts 251

Interventions

Verapamil 1Tablets 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Diabetes Mellitus × Other hematologic neoplasm × Clear all
NCT04233034 2024-11-27

CLVer

Jaeb Center for Health Research

Phase 3 Completed
113 enrolled 42 charts
Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

NCT01486043 2015-01-30

Metformin and Transient Hyperglycemia

Children's Hospital Los Angeles

Phase NA Terminated
4 enrolled 9 charts
LymphoidOther hematologic neoplasm

Diabetes Mellitus, Hyperglycemia, Insulin Resistance, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡